The aim of the study was to determine serum free amino acid concentration in male dogs suffering from benign and malignant perianal tumours. Serum concentrations of cysteic acid, glutamic acid, glutamine, aspartic acid, glycine, γ-aminobutyric acid, tryptophan, methionine, arginine, taurine, threonine, tyrosine, alanine, valine, isoleucine, and leucine were significantly changed in dogs suffering from benign and/or malignant tumours when compared to the control group (P<0.05). Serum concentration of serine, phenylalanine, lysine and histidine was not influenced in dogs with neoplastic disease (P>0.05). The evaluation of serum free amino acid concentration, has shown that threonine, glutamic acid, alanine, valine, isoleucine, leucine, γ-aminobutyric acid, and glycine have the highest diagnostic and prognostic value in dogs suffering from benign and malignant perianal tumours. Highly diagnostic and prognostic value in relation to benign tumour growth was also found while evaluating branched chain and acidic groups of amino acids. Serine, phenylalanine, lysine, and histidine, as well as alkaline amino acids were proved not to have diagnostic and prognostic value in dogs with the tumours. Thus, the evaluation of free amino acid concentration may serve diagnostic purposes and help in tumour malignancy differentiation. The elaborated experimental model may be used in further studies on neoplastic disease development and monitoring of applied treatment efficiency.
Epidemiological data indicate an increasing incidence of neoplastic diseases in animals, especially those living at the area of large industrialised agglomerations (1, 2, 10) . Among oncological diseases in dogs, the most frequent are skin neoplasms reaching up to one third of all cases (5) . Neoplasms in the perianal region, originating from perianal glands, reach about 15%-17% of skin neoplastic cases and their occurrence in old males is very high in comparison to females or castrated males suffering occasionally from such problems. Sexual dimorphism of these glands is evident and significant regression occurs in females with structural characteristics indicating degeneration and formation of isolated islands of apocrine cells. Most of these adenomas are of benign character but some of them are malignant tumours. Clinical investigations have shown both single and multiple forms of the neoplasms, and confirmed serious care difficulty for patient's owners due to frequent bleeding. Specific localisation, limited mainly to the perianal region, and nodular characteristics of the neoplasms result from their glandular origin (18) . The aetiology of the tumours has not been explained so far but it was found that their growth can be modulated by sexual hormones, mainly androgens (11) . Adenocarcinomas are sometimes followed by systemic symptoms such as apathy, muscle weakness, polyuria, and polidypsia connected with hypocalcaemia and hypophosphatemia (3) . Even though all types of tumours may develop in this area, the adenomas represent over 80%. Metastases from perianal carcinomas may occur in the lungs, liver, spleen, and illiac and lumbar lymph nodes (25, 33) .
Investigations on animals suffering from neoplastic diseases revealed that the tumour growth stimulates protein metabolism and changes in amino acid (AA) profile in the blood. Apart from the changes in profiles of single free amino acids, the whole groups of amino acid, such as: sulfur-containing, acidic, alkaline, aromatic, and branched chain may be influenced. It was suggested that different tumours may have various influence on metabolism and serum profile of free amino acids in a type-specific manner (6) . Experimental studies have revealed interrelationships between amino acid concentration in neoplastic tissue and in serum. The observed correlations indicate metabolic competition of amino acids between neoplastic and normal healthy tissues. Due to a huge contribution of protein synthesis in growing tumours, it was found that the metabolism of sulphur-containing amino acids is most significantly influenced under such conditions. Thus, serum evaluation of amino acids may be considered as a valuable method for diagnosis and treatment of patients suffering from neoplastic diseases (19, 20, 30, 31) .
Considering these data, the aim of the study was to determine and compare free amino acid concentration in serum of dogs suffering from both benign and malignant perianal tumours. The comparison was performed for single free amino acids and for the amino acids belonging to acidic, alkaline, aromatic, and branched chain groups.
Material and Methods
Experimental design and sampling procedure. Serum concentration of free amino acids was determined in samples obtained from male dogs suffering from perianal benign and malignant tumours. All patients underwent treatment between 2008 and 2011 in the Clinic. Age of the dogs varied between 8 and 15 years. The investigation was performed on 45 patients: three poodles, five spaniels, six dachshunds, two ratters, four fox terriers, eight German Shepherds, and 17 crossbreed dogs. Blood sampling was performed under pharmacological sedation with xylazine (Sedasin®, Biowet Pulawy, Poland) at the dose of 2 mg/kg b.w. Blood was collected to plastic tubes, centrifuged after clothing at 3,000 rpm for 15 min, and stored at -18˚C until analysis. To differentiate tumour type, the neoplastic tissue samples (5 mm in diameter) were collected during biopsy performed in local anaesthesia with the use of 2% lignocainum hydrochloricum. The samples were fixed in 10% buffered formalin and paraffin sections were analysed histopathologically at the Department of Pathological Anatomy, Faculty of Veterinary Medicine, University of Life Sciences in Lublin. On the basis of histopathological examination, the patients were divided into two groups: dogs suffering from malignant tumours (n=21) and dogs suffering from benign tumours (n=24). Dogs showing good health status but qualified to surgery due to diseases different than neoplastic disease, were assigned to the control group (n=17).
Amino acid analysis. The determination of serum concentration of free amino acids was performed using ion-exchange chromatography on INGOS AAA-400 apparatus for automatic analysis of amino acids (Ingos Corp., Czech Republic). One millilitre of serum was added to 1 mL of 6.0% sulphosalicylic acid buffered, pH 2.9. Then the sample was centrifuged for 15 min at 12,000 rpm using the centrifuge MPW 250 (MPW MED. INSTUMENTS, Poland). The obtained supernatant was used for the determination of free amino acids. Amino acids were separated on analytic column (OSTION LG FA, 3 mm x 200 mm). During the separation, five lithium citrate buffers of different pH (2.9, 3.1, 3.35, 4.05, and 4.9) were used. The amino acids were derivatized with ninhydrin and their identification was performed on the basis of retention time in comparison to the standards using photocell combined with a computer. Analytical separation of acidic and alkaline amino acids was performed at 38-39˚C, while neutral amino acids were separated at 59-60˚C. The original software MIKRO version 1.8.0 (Ingos Corp., Czech Republic) was used for amino acid evaluation (15, 27, 28) .
Statistical analysis. All values are presented as means ±SEM. Statistical analysis was performed using Statistica software (version 6.0) and one-way analysis of variance (ANOVA). Tukey's post-hoc test was used to compare differences between the investigated groups of dogs. A statistical comparison was performed for single free amino acids and amino acids belonging to acidic (aspartic acid, glutamic acid), alkaline (arginine, histidine, lysine), aromatic (tryptophan, tyrosine, phenyloalanine), and branched chain (leucine, isoleucine, valine) groups. Mean values obtained for particular amino acids within each group were added to evaluate amino acid groups statistically. The differences between the mean values were considered as statistically significant at P<0.05.
Results
Free amino acid concentration in serum of control dogs and those suffering from benign or malignant tumours are presented in Table 1 . Significantly higher values of serum concentration of aspartic acid, methionine, tyrozine, tryptophan, and arginine were found in dogs suffering from the tumours when compared to the control group (P<0.05). Serum concentration of cysteic acid and glutamine was significantly decreased in both groups suffering from neoplastic disease when compared to the controls (P<0.05). On the other hand, glycine concentration was significantly higher in serum of dogs suffering from malignant tumours in comparison to the value of control group. The opposite results were stated comparing γ-aminobutyric acid (GABA) concentration in these groups (P<0.05). Tryptophan, methionine, and arginine reached significantly higher concentrations in serum of dogs with malignant tumours in comparison to those possessing benign neoplastic changes (P<0.05). Taurine concentration was significantly lower in dogs with benign tumours when compared to the groups suffering from malignant tumours (P=0.02). Serum concentrations of threonine, glutamic acid, alanine, valine, isoleucine, and leucine were significantly higher in dogs suffering from benign tumours when compared to the control group and the group with malignant neoplasms (P<0.05).
Results of the evaluations of aromatic, alkaline, acidic, and branched chain amino acids (BCAA) concentrations in dogs' serum are shown in Table 2 . The concentrations of the amino acids were significantly increasing in dogs with benign tumours when compared to the control group (P≤0.001). Furthermore, the concentration of aromatic amino acids was significantly higher in dogs suffering from malignant tumours when compared to the group with the non-malignant tumours (P= 0.0001). 
Discussion
Changes in amino acid metabolism in neoplastic tissues and serum result from accelerated cell proliferation and growth occurring in tumour milieu in both humans and animals (13, 20, 21, 29) . It was shown that tumour growth-related changes in protein metabolism and amino acid profile depend on malignancy stage. Development and growth of malignant tumours lead to a significant increase in the affected tissue mass and require enhanced protein synthesis from locally present amino acids, as well as, those in blood (12, 29) . Thus, in the study, the evaluation of the differences in single free AAs and groups of amino acids in serum between healthy dogs and those suffering from non-malignant or malignant tumours were chosen as criterion for diagnostic and prognostic purposes.
Previous studies in humans have revealed that glutamic acid concentration increases in tumour tissue when compared to unaffected tissues, and these changes are strongly related to advancement of malignancy stage of the neoplastic process (19, 22, 23) . Similar results were reported in studies on dogs with mammary gland tumours and skin tumours, where evaluation of amino acids in malignant tumour tissues and serum has shown increased glutamic acid concentration in both these compartments when compared to healthy controls. While serum concentration of glutamic acid increased two-fold in dogs suffering from malignant tumours of skin, the assessment of the amino acid in serum of dogs with mammary gland tumours has shown a 28-fold increase (4, 5) . Similarly to the results of the mentioned studies on humans and dogs, serum changes in glutamic acid concentration was observed in the study. Accordingly to the data reported previously, serum glutamic acid concentration was 3.5-fold increased in the dogs suffering from benign perianal tumours when compared to the controls. Unfortunately, the assessment of amino acids in perianal tumour tissue was impossible in the study due to the facts that all patients were qualified to pharmacological treatment and the tissue samples obtained for histopathological evaluation were too small to be analysed. It should be pointed out that it is not unusual to find contrasting data related to the determined glutamic acid concentrations in serum. This finding diminishes the possible use of glutamic acid as a valuable biochemical marker for assessment of neoplastic process development or the effectiveness of tumour treatment monitoring. As reported by Ollenschlager et al. (23) , the relationships between glutamic acid concentration and neoplastic disease stage were not found, even though the increased serum level of this amino acid was stated in patients with neoplastic disease. On the other hand, serum amino acid evaluation showed increased levels of glutamic and aspartic acids in patients suffering from small-cell lung cancer, which represented highly malignant type of carcinoma. As suggested in the study, assessment of amino acid profile in serum of patients with malignant neoplastic disease and at the risk of tumour recurrence would have diagnostic and prognostic value, especially in terms of glutamic and aspartic acid concentrations (26, 30) . This statement was confirmed in the study since a significantly increased serum concentration of aspartic acid was found in dogs suffering from benign or malignant tumours. It is interesting that the observed aspartic acid concentration changes showed a similar increase in the investigated groups versus control dogs (40% and 33%, respectively). The results obtained in the study correspond also with other investigations on neoplastic diseases, where increased amino acid metabolism was reported. It was shown that a substantial amount of methionine incorporated into glioma cells with and without bloodbrain barrier disruption (14) . However, differentiated amount of blood, resulting from the perfusion throughout tumour tissue, may change the methionine uptake, indicating that partial amino acid uptake results from their passive diffusion determined by blood flow dynamic (24) . Similarly to those data, the study revealed a significant increase in serum methionine concentration in dogs possessing benign or malignant tumours. Increased serum tyrosine concentration in dogs from both groups with neoplastic changes remains in the agreement with studies on rat rhabdomyosarcoma model in which associations between tumour growth rate and tyrosine uptake were found (9) . Moreover, hyperthermia-induced inhibition of tyrosine uptake correlated significantly with tumour regression (8) . The increased serum concentration of glycine, alanine, valine, leucine, tyrosine, and tryptophan noticed in the study in dogs suffering from benign or malignant tumours may be explained as a metabolic response to a higher protein demand of proliferating neoplastic cells, especially when the presence of developed carrier-mediated processes and membrane transporter proteins for these amino acids within tumour cells are considered. In general, amino acid transport is increased in neoplastic transformation conditions; however, except for transmembrane transport systems, amino acid diffusion into growing cells may significantly contribute to increased protein synthesis in tumour (14) . Thus, the observed significant increase in serum concentrations of all amino acids in dogs possessing neoplastic changes may be connected with enhanced transport and metabolic processes. Additionally, it should be noted that the observed reduced serum concentration of glutamine in dogs with perianal tumours is associated with higher glutamic acid level, since glutamine may be easily converted into glutamic acid (32) . The decreased serum glutamine concentration in tumour-affected dogs may also result from its reduced amount in the intracellular and extracellular compartments at hypercatabolic pathological state, such as neoplastic disease (34) . Furthermore, the observed differences in serum concentration of taurine, threonine, glutamic acid, glycine, alanine, GABA, valine, methionine, isoleucine, leucine, tryptophan, and arginine between the groups with benign or malignant tumours may result from diverse course of metabolic processes in dogs suffering from different tumour types in term of malignancy. The explanation of the observed differences in serum concentration of cysteic acid and GABA between the experimental and control groups of dogs require further investigation, since literature data within this area are strongly limited.
The study also revealed a significant increase in serum concentration of aromatic amino acids in dogs suffering from benign or malignant tumours when compared to the healthy control group. Furthermore, aromatic AAs concentration was found to be significantly higher in dogs with malignant neoplastic changes when compared to those with benign tumours. These observations may be explained by the data showing that aromatic amino acids serve as the substrates for aromatic amino acid decarboxylase (AADC), the level of which is enhanced in endocrine tumours. Increased uptake of aromatic amino acids and their subsequent decarboxylation results in intracellular accumulation of the amino acids and their decarboxylation products in neoplastic cells, which leads to significantly changed levels of aromatic amino acids in serum. Considering the variable concentration of aromatic AAs observed in the study between dogs with non-malignant and malignant changes, it may be hypothesised that aromatic AA metabolism increases in accordance to tumour malignancy stage (16) . In case of alkaline amino acids, lack of significant changes in serum concentrations of dogs with non-malignant or malignant tumours may limit their diagnostic value related to perianal tumour type differentiation and further tumour growth prognosis. The results of evaluation of branched chain and acidic AAs in serum indicate that the elevated concentrations of these groups are characteristic for benign perianal tumour development and may be a valuable predictor of the character of neoplastic processes in dogs. Taking under consideration the results from the study, prediction of tumour malignancy by assessment of sulphur-containing amino acids seems to be limited due to the fact that cysteine and cystine in serum were not evaluated. In opposition to the observations, the results of experimental studies on humans have shown that aromatic amino acid concentration increases in subjects suffering from neoplastic processes of the gastrointestinal tract, while BCAAs level decreases in such patients (13, 17, 31) . Other data from research conducted on humans demonstrated changes in BCAAs concentration in patients with various neoplastic diseases, although total amino acid level was decreased (7, 17, 21) .
This study has revealed that benign and malignant perianal tumours lead to significant changes of serum amino acid concentration. On the basis of the results obtained, the evaluated amino acids may be classified into three groups depending on their diagnostic and prognostic value in dogs with perianal tumours. The first group possessing highly diagnostic and prognostic value in relation to benign tumour growth may be distinguished by increased concentration of threonine, glutamic acid, alanine, valine, isoleucine, and leucine when compared to healthy dogs or those suffering from malignant perianal tumours. The same observations were obtained for branched chain and acidic groups of AAs. In case of the animals with malignant neoplastic changes, decreased GABA and increased glycine concentration in serum were specific when compared to the other groups. In the second group of AAs with moderate diagnostic and prognostic value, the highest serum concentrations of methionine, tryptophan, and arginine were characteristic for malignant tumours when compared to dogs with benign neoplasms, in which these concentrations were increased moderately, and in comparison to healthy dogs. The same changes were stated in the group of aromatic AAs. The third group with relatively poor prognostic value may include glutamine, aspartic acid, cysteic acid, and tyrosine, due to the same changes of their serum concentrations in dogs with non-malignant or malignant neoplastic processes when compared to healthy controls. However, a decreased serum concentration of cysteic acid and glutamine, as well as increased serum concentration of aspartic acid and tyrosine indicate the development of neoplastic disease and may be useful to differentiate such patients from healthy dogs. On the other hand, the observed differences in taurine concentration between the groups with malignant and benign tumours seem to have a questionable diagnostic value due to the similar concentration of these amino acids in healthy controls. The concentrations of serine, phenylalanine, lysine, and histidine, as well as the alkaline group of AAs did not differ significantly between control and experimental dogs, hence these amino acids have limited diagnostic and prognostic value in dogs with perianal tumours. Thus, the evaluation of serum concentration of free amino acids may serve diagnostic purposes and can be helpful in tumour malignancy differentiation. The elaborated experimental model may be useful in further studies on neoplastic disease development and monitoring of treatment efficiency.
